"...highly unlikely UCI has any sort of say over whether Cortex gets bought out."
well, that sounds right; i don't think uci cares who pays them their cut.
there is probably a 200 page agreement put together by two teams of lawyers in a language that at times may seem similar to english that states something like "render unto ceaser what is ceaser's, render unto God what is God's." i'll let you decide which one is cortex and which one is uci.
I have never heard of a pharma/academia agreement that gives the university any veto power over management decisions. There are sometimes--as is the case with UC/Cortex-- performance milestones, to make sure the company is doing something productive with the license, but in the long run, the university just wants a return on its IP investment.
I’ve never heard of an academic licensor having explicit control over the licensee’s business dealings, but I know of cases where there is implicit control via the economic terms of the license. The license that IDIX has with the University of Alabama is one such case.